Optimising Anaemia Management with Epoetin Beta

Publisher： Karger

E-ISSN： 1423-0232|67|1|12-16

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.1, 2004-10, pp. : 12-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anaemia Management Strategies: Optimising Treatment Using Epoetin Beta (NeoRecormon^®)

Oncology, Vol. 69, Iss. 2, 2005-10 ,pp. : 8-16

Karger

Access to resources Recommend Favorite

Evolving Treatment Strategies for Anaemia in Cancer: Experience with Epoetin Beta

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 17-22

Karger

Access to resources Recommend Favorite

Epoetin delta is effective for the management of anaemia associated with chronic kidney disease

By Spinowitz Bruce S. Pratt Raymond D.

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2507-2513

Informa Healthcare

Access to resources Recommend Favorite

Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients

By Kwan Jonathan T. C. Pratt Raymond D.

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 307-311

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the therapeutic effects of epoetin zeta and epoetin alfa in the correction of renal anaemia

By Krivoshiev Stefan Todorov Vasil V. Manitius Jacek Czekalski Stanislaw Scigalla Paul Koytchev Rossen

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1407-1415

Informa Healthcare

Access to resources Recommend Favorite